• Brivaracetam, Plasma
  • Primary Hyperoxaluria Gene Mutation Panel
  • Aspergillus DNA, Qualitative, Real-Time PCR, CSF
  • Normetanephrine, Plasma
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • Haemophilus ducreyi, Culture
  • KRAS Gene Mutation Analysis
  • Phospholipase C Gamma 2 (PLCG2) Gene Mutation Analysis
  • Idiopathic Pulmonary Fibrosis Diagnostic Test (Envisia™)
  • Clostridium difficile (C. Diff), Culture
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 72-4
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 72-4
Medical Test

Turnaround Time
Access to Cancer Antigen (CA) 72-4 is restricted.
Loading...